Are Options Traders Betting on a Big Move in Cassava Sciences (SAVA) Stock?Zacks Investment Research • 05/25/21
Cassava Sciences to Participate in Q&A Panel Discussion on Alzheimer's DiseaseGlobeNewsWire • 05/24/21
Long-Term Small Molecule Studies Bode Well For Cassava Sciences' Alzheimer's DataSeeking Alpha • 05/18/21
Caladrius Biosciences, Cassava Sciences Secure Non-Dilutive Funding For Product DevelopmentBenzinga • 05/12/21
Cassava Sciences Announces New $2.7 Million Research Grant Award from National Institutes of HealthGlobeNewsWire • 05/12/21
Cassava Sciences Announces Initiation of Cognition Maintenance Study in Alzheimer's diseaseGlobeNewsWire • 05/10/21
Cassava Sciences Invited by the NIH to Participate in Sachs 4th Annual Neuroscience Innovation ForumGlobeNewsWire • 04/26/21
Cassava Sciences Reports First Quarter 2021 Financial Results and Announces Guidance on Clinical Data ReleaseGlobeNewsWire • 04/21/21
5 High-Flying Stocks That Turned $200,000 Into More Than $1 Million in 3 MonthsThe Motley Fool • 03/27/21
Has Cassava Sciences (SAVA) Outpaced Other Medical Stocks This Year?Zacks Investment Research • 03/24/21
Anavex And Cassava Sciences: Closer To An Understanding Of Alzheimer's DiseaseSeeking Alpha • 03/23/21
Cassava Sciences Announces Full-year 2020 Financial Results and Business HighlightsGlobeNewsWire • 03/23/21